EC Number |
Inhibitors |
Structure |
---|
2.7.7.101 | (2E)-3-(6-chloro-2H-chromen-3-yl)acrylic acid |
- |
|
2.7.7.101 | (7S)-7-[(2R,4S,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-ethyl-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione |
- |
|
2.7.7.101 | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl] oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
- |
|
2.7.7.101 | 1-(3-((3-(o-tolyl)-1,2,4-oxadiazol-5-yl)methyl)piperidin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethan-1-one |
- |
|
2.7.7.101 | 1-(4-methyl-2-nitrophenoxy)-3-[4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazino]propan-2-ol |
- |
|
2.7.7.101 | 2'-deoxy-2'-azidocytidine 5'-triphosphate |
pronounced inhibition, not reversed by presence of dCTP or CTP. Inhibitor is incorporated into the primer and terminates the extension of the primer strand |
|
2.7.7.101 | 2-((1H-indol-3-yl)thio)acetic acid |
- |
|
2.7.7.101 | 2-fluoro-AraATP |
- |
|
2.7.7.101 | 3-[2-(ethoxycarbonyl)-5-nitro-1H-indol-3-yl]propanoic acid |
- |
|
2.7.7.101 | 4-fluorophenyl tetrazole |
- |
|